Table 4. Change in cost development when prolonging the stay in the Mild stage by one or two years.

Costs from staying in the Mild stage for one more year
	2030	2040	2050	2060	2070	2080
Mild	30.3	48.0	60.4	70.3	76.1	79.0
	113.66%	117.37%	118.29%	119.09%	119.81%	120.00%
Moderate	−5.8	−0.2	1.5	3.1	4.6	5.3
	95.15%	99.86%	100.81%	101.49%	102.15%	102.40%
Severe	−8.0	−4.5	−4.1	−3.8	−3.1	-2.7
	89.86%	95.47%	96.62%	97.27%	97.91%	98.22%
Overall	16.5	43.2	57.8	69.6	77.6	81.7
	103.92%	108.24%	109.14%	109.77%	110.38%	110.61%
Costs from staying in the Mild stage for two more years
	2030	2040	2050	2060	2070	2080
Mild	55.8	92.2	118.0	138.2	150.4	156.8
	125.13%	133.41%	135.70%	137.53%	139.17%	139.67%
Moderate	−18.4	−11.0	−9.8	−8.4	−6.3	−5.3
	84.59%	92.64%	94.60%	95.89%	97.10%	97.61%
Severe	−18.9	−15.0	−15.6	−16.1	−15.4	−15.0
	76.19%	84.89%	87.16%	88.40%	89.59%	90.19%
Overall	18.5	66.2	92.6	113.7	128.7	136.5
	104.40%	112.61%	114.64%	115.97%	117.21%	117.73%